Exploring microvascular inflammation and the spectrum of antibody-mediated rejection
- PMID: 39218157
- DOI: 10.1016/j.ajt.2024.08.028
Exploring microvascular inflammation and the spectrum of antibody-mediated rejection
Conflict of interest statement
Declaration of competing interests The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. L.D.C. reports consulting agreements with argenx and Amgen. I.H. reports a research grant from Hansa Biopharma and ongoing consultancy agreements with AstraZeneca, Hansa Biopharma, MSD, Sandoz, and Takeda.
Publication types
LinkOut - more resources
Full Text Sources
